glp-1 ckd receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease Preventing diabetic kidney disease progression:
Description
doi: 10.1007/s40618-017-0798-4
Aunque histricamente se ha considerado que su efecto en la obesidad es limitado, estudios recientes han sugerido que, en combinacin con el GLP-1, el GIP puede potenciar la accin insulnica y modular la respuesta adipognica
Effects of glucagon-like peptide-1 and sympathetic stimulation on gastric accommodation in humans
E., Khan, S., Alemu, R., Locke, A., Lai, V., He, H., Hittle, L., Wang, W., Drucker, D
When you're already dealing with reduced appetite from GLP-1s, this might seem counterintuitive
